Related Experiment Video
Updated: Mar 22, 2026

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Published on: September 13, 2018
Small Non-coding RNAs Associated with Viral Infectious Diseases of Veterinary Importance: Potential Clinical
Mohamed Samir1, Frank Pessler2
1TWINCORE Center for Experimental and Clinical Infection Research, Hannover, Germany; Zoonoses Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Abstract:
MicroRNAs (miRNAs) represent a class of small non-coding RNA (sncRNA) molecules that can regulate mRNAs by inducing their degradation or by blocking translation. Considering that miRNAs are ubiquitous, stable, and conserved across animal species, it seems feasible to exploit them for clinical applications. Unlike in human viral diseases, where some miRNA-based molecules have progressed to clinical application, in veterinary medicine, this concept is just starting to come into view. Clinically, miRNAs could represent powerful diagnostic tools to pinpoint animal viral diseases and/or prognostic tools to follow up disease progression or remission. Additionally, the possible consequences of miRNA dysregulation make them potential therapeutic targets and open the possibilities to use them as tools to generate viral disease-resistant livestock. This review presents an update of preclinical studies on using sncRNAs to combat viral diseases that affect pet and farm animals. Moreover, we discuss the possibilities and challenges of bringing these bench-based discoveries to the veterinary clinic.
Insights
MicroRNAs (miRNAs) show promise for diagnosing and treating animal viral diseases. This review explores preclinical studies and challenges for veterinary clinical applications of these small non-coding RNAs.
Area of Science:
- Veterinary Medicine
- Molecular Biology
- Virology
Background:
- MicroRNAs (miRNAs) are small non-coding RNA molecules regulating gene expression.
- miRNAs are stable, conserved, and ubiquitous, suggesting clinical potential.
- miRNA applications are established in human viral diseases but emerging in veterinary medicine.
Purpose of the Study:
- To review preclinical studies on using small non-coding RNAs (sncRNAs) against viral diseases in animals.
- To discuss the clinical translation of sncRNA-based strategies for veterinary applications.
- To highlight the diagnostic, prognostic, and therapeutic potential of miRNAs in veterinary virology.
Main Methods:
- Literature review of preclinical studies on sncRNAs and animal viral diseases.
- Analysis of current research on miRNA-based diagnostics and therapeutics.
- Discussion of challenges and opportunities for clinical implementation.
Main Results:
- Preclinical studies demonstrate the potential of sncRNAs to combat viral infections in pets and farm animals.
- miRNAs can serve as biomarkers for disease diagnosis and prognosis.
- Dysregulated miRNAs present therapeutic targets and tools for developing disease-resistant livestock.
Conclusions:
- Small non-coding RNAs, particularly miRNAs, offer significant potential for veterinary clinical applications.
- Further research and development are needed to overcome challenges in translating these findings to the clinic.
- sncRNAs could revolutionize the diagnosis, treatment, and prevention of viral diseases in animals.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Subviral Agents

